Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2138-2156
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2138
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2138
Table 5 Relationship between the expression of sine oculis homeobox homolog 4 and clinicopathological parameters of colon cancer patients
Clinicopathological parameter | n | SIX4 expression | χ2 | P value | |
Low | High | ||||
Age | |||||
≤ 60 yr | 22 | 10 (45.5%) | 12 (54.5%) | 1.558 | 0.2120 |
> 60 yr | 71 | 22 (31.0%) | 49 (69.0%) | ||
Sex | |||||
Male | 44 | 17 (38.6%) | 27 (61.4%) | 0.6614 | 0.4161 |
Female | 49 | 15 (30.6%) | 34 (69.4%) | ||
Maximum tumor diameter1 | |||||
< 5 cm | 37 | 13 (35.1%) | 24 (64.9%) | 0.0034 | 0.9563 |
≥ 5 cm | 55 | 19 (34.5%) | 36 (65.5%) | ||
Pathological stage | |||||
I-II | 78 | 29 (37.2%) | 49 (62.8%) | - | 0.2470 |
III | 15 | 3 (20.0%) | 12 (80.0%) | ||
Primary tumor | |||||
T1-T2 | 5 | 2 (40.0%) | 3 (60.0%) | 0.0696 | 0.9658 |
T3 | 70 | 24 (34.3%) | 46 (65.7%) | ||
T4 | 17 | 6 (35.3%) | 11 (64.7%) | ||
N | |||||
N0 | 58 | 24 (41.4%) | 34 (58.6%) | 3.318 | 0.0685 |
N1-N2 | 35 | 8 (22.9%) | 27 (77.1%) |
- Citation: Fang ZX, Li CL, Wu Z, Hou YY, Wu HT, Liu J. Comprehensive analysis of the potential role and prognostic value of sine oculis homeobox homolog family in colorectal cancer. World J Gastrointest Oncol 2022; 14(11): 2138-2156
- URL: https://www.wjgnet.com/1948-5204/full/v14/i11/2138.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i11.2138